Drawing for TRIAGETRUE

USPTO serial 99641282

TRIAGETRUE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
KNIGHT, TROY FRANK
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with TRIAGETRUE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alexis Crawford Douglas

Alexis Crawford Douglas K&L Gates LLPP.O. Box 1135Chicago, IL 60690-1135United States

Goods and services

ClassDescriptionStatusFirst use
005In vitro medical diagnostic test kits for clinical, professional, medical or consumer use consisting primarily of reagents together with test equipment in the nature of a medical testing device for monitoring patient conditions and diagnosing disease; chemical, biochemical and biological preparations for medical use in cassette form, namely, for use in measuring, testing and analyzing blood and other bodily fluids; chemical reagents in cassette form for medical purposes, namely, for use in connection with diagnostic test kits for the detection of a wide variety of diseases, conditions, and disorders; medical diagnostic reagent test kits comprised of customized microscopy slides being medical specimen collection devices for medical use, detection and/or identification staining reagents, and associated quality control reagents, for medical useACTIVE—
009Automated fluorescent-based microscopy system comprised of light-emitting diodes (LED), photodiode, motorized cassette slide carrier being a microscope part, and embedded diagnostic software for data reduction; downloadable computer software for capturing, organizing, reporting, and management of medical information and dataACTIVE—
010Devices in the nature of cups and bags for the collection of bodily excretions and fluids from humans for medical diagnostic purposes; devices in the nature of cups, bags and test components in the nature of medical testing devices for detecting pathogens and biomarkers sold as a kit for the collection of bodily fluids from humans for clinical medical diagnostic purposes; medical diagnostic apparatus comprised of a port for a reagent test and a fluorescence light source, specifically adapted for reading in vitro medical test results for detecting pathogens and biomarkers; medical diagnostic analyzers for measuring, testing and analyzing blood and other bodily fluids; medical diagnostic reagent test kits comprised of customized microscopy slides being medical specimen collection devices and also comprised of detection and/or identification staining reagents and associated quality control reagents; automated diagnostic instrument for clinical medical laboratory use in detecting pathogens; clinical medical laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; automated clinical diagnostic instruments and devices for measuring, detecting, testing, monitoring, or analyzing biological samples; diagnostic apparatus for clinical medical laboratory use for measuring, detecting, testing, monitoring, or analyzing biological samplesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 3, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 3, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 28, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 30, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 15, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 15, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 15, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 25, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 25, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 25, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 7, 2026DOCKASSIGNED TO EXAMINER—
Jun 5, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 9, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 9, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance